Effect of GPE-AGT nanoparticle shRNA transfection system mediated RNAi on early atherosclerotic lesion

International Journal of Clinical and Experimental Pathology

Volumn 5, Issue 7, 2012, Pages 698-706

  Lu, Ping ^a   Yuan, Lifen ^a   Wang, Yuqiang ^a   Du, Qin ^a   Sheng, Jing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Angiotensinogen; Animal model; Atherosclerosis; Hypertension; RNA interference; Spontaneously hypertensive rat

Indexed keywords

ANGIOTENSIN DERIVATIVE; MESSENGER RNA; NANOPARTICLE; SMALL INTERFERING RNA;

ANIMAL; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; CAROTID ARTERY; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HEART RATE; HYPERTENSION; LIPID DIET; LIVER; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RAT; RNA INTERFERENCE; SPONTANEOUSLY HYPERTENSIVE RAT;

ANGIOTENSINS; ANIMALS; ATHEROSCLEROSIS; BLOOD PRESSURE; CAROTID ARTERIES; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HEART RATE; HYPERTENSION; LIVER; NANOPARTICLES; RATS; RATS, INBRED SHR; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84866011910     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Mahfouz RA, El Tahlawi MA, Ateya AA and Elsaied A. Early detection of silent ischemia and diastolic dysfunction in asymptomatic young hypertensive patients. Echocardiography 20-11; 28: 564-569.
2. Bol V, Desjardins F, Reusens B, Balligand JL and Remacle C. Does early mismatched nutrition predispose to hypertension and atherosclerosis, in male mice? PLoS One 2010; 5
3. Cassis LA, Gupte M, Thayer S, Zhang X, Charnigo R, Howatt DA, Rateri DL and Daugherty A. ANG II infusion promotes abdominal aortic an-eurysms independent of increased blood pressure in hypercholesterolemic mice. Am J Physiol Heart Circ Physiol 2009; 296: H1660-1665.
4. Ferrario CM and Strawn WB. Role of the reninangiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol 2006; 98: 121-128.
5. Jain S, Vinukonda G, Fiering SN and Kumar A. A haplotype of human angiotensinogen gene containing -217A increases blood pressure in transgenic mice compared with -217G. Am J Physiol Regul Integr Comp Physiol 2008; 295: R1849-1857.
6. Norat T, Bowman R, Luben R, Welch A, Khaw KT, Wareham N and Bingham S. Blood pressure and interactions between the angiotensin polymorphism AGT M235T and sodium intake: a cross-sectional population study. Am J Clin Nutr 2008; 88: 392-397.
7. Xu P, Wang Y, Sterner-Kock A, Bader M, Schultheiss HP and Walther T. Excessive hypertension and end-organ damage in a transgenic mouse line carrying the rat angiotensinogen gene. J Cardiovasc Pharmacol 2009; 53: 38-43.
8. Paravicini TM and Touyz RM. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 2008; 31 Suppl 2: S170-180.
9. Gong H, Liu CM, Liu DP and Liang CC. The role of small RNAs in human diseases: potential troublemaker and therapeutic tools. Med Res Rev 2005; 25: 361-381.
10. de Wolf HK, Johansson N, Thong AT, Snel CJ, Mastrobattista E, Hennink WE and Storm G. Plasmid CpG depletion improves degree and duration of tumor gene expression after intravenous administration of polyplexes. Pharm Res 2008; 25: 1654-1662.
11. Regnstrom K, Ragnarsson EG, Fryknas M, Koping-Hoggard M and Artursson P. Gene expression profiles in mouse lung tissue after administration of two cationic polymers used for nonviral gene delivery. Pharm Res 2006; 23: 475-482.
12. Wang YQ, Su J, Wu F, Lu P, Yuan LF, Yuan WE, Sheng J and Jin T. Biscarbamate cross-linked polyethylenimine derivative with low molecular weight, low cytotoxicity, and high efficiency for gene delivery. Int J Nanomedicine 2012; 7: 693-704.
13. Lin-Lee YC, Tanaka Y, Lin CT and Chan L. Effects of an atherogenic diet on apolipoprotein E biosynthesis in the rat. Biochemistry 1981; 20: 6474-6480.
14. Widdop RE and Li XC. A simple versatile method for measuring tail cuff systolic blood pressure in conscious rats. Clin Sci (Lond) 1997; 93: 191-194.
15. Sonoda M, Aoyagi T, Takenaka K, Uno K and Nagai R. A one-year study of the antiatherosclerotic effect of the angiotensin-II receptor blocker losartan in hypertensive patients. A comparison with angiotension-converting enzyme inhibitors. Int Heart J 2008; 49: 95-103.
16. Raizada V, Skipper B, Luo W and Griffith J. Intracardiac and intrarenal renin-angiotensin systems: mechanisms of cardiovascular and renal effects. J Investig Med 2007; 55: 341-359.
17. Zhu X, Chang YP, Yan D, Weder A, Cooper R, Luke A, Kan D and Chakravarti A. Associations between hypertension and genes in the reninangiotensin system. Hypertension 2003; 41: 1027-1034.
18. Ferrario CM. Use of angiotensin II receptor blockers in animal models of atherosclerosis. Am J Hypertens 2002; 15: 9S-13S.
19. Blake GJ and Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res 2001; 89: 763-771.
20. Ikeda F, Azuma K, Ogihara T, Toyofuku Y, Otsuka A, Mita T, Hirose T, Tanaka Y, Kawamori R and Watada H. Angiotensin II type 1 receptor blocker reduces monocyte adhesion to endothelial cells in spontaneously hypertensive rats. Endocr J 2007; 54: 605-612.
21. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, Asmar R, Reneman RS, Hoeks AP, Breteler MM and Witteman JC. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006; 113: 657-663.
22. Jensky NE, Criqui MH, Wright MC, Wassel CL, Brody SA and Allison MA. Blood pressure and vascular calcification. Hypertension 2010; 55: 990-997.
23. Hitomi H, Kiyomoto H and Nishiyama A. Angiotensin II and oxidative stress. Curr Opin Cardiol 2007; 22: 311-315.
24. Zhou J, Pavel J, Macova M, Yu ZX, Imboden H, Ge L, Nishioku T, Dou J, Delgiacco E and Saavedra JM. AT1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats. Stroke 2006; 37: 1271-1276.
25. Ghiadoni L, Versari D, Magagna A, Kardasz I, Plantinga Y, Giannarelli C, Taddei S and Salvetti A. Ramipril dose-dependently increases nitric oxide availability in the radial artery of essential hypertension patients. J Hypertens 20-07; 25: 361-366.